Otrexup
List of products in the National Drug Code with proprietary name otrexup. Methotrexate is used to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
54436-010 | Otrexup | Methotrexate | Injection, Solution | Subcutaneous | Antares Pharma, Inc. | Human Prescription Drug |
54436-012 | Otrexup | Methotrexate | Injection, Solution | Subcutaneous | Antares Pharma, Inc. | Human Prescription Drug |
54436-015 | Otrexup | Methotrexate | Injection, Solution | Subcutaneous | Antares Pharma, Inc. | Human Prescription Drug |
54436-017 | Otrexup | Methotrexate | Injection, Solution | Subcutaneous | Antares Pharma, Inc. | Human Prescription Drug |
54436-020 | Otrexup | Methotrexate | Injection, Solution | Subcutaneous | Antares Pharma, Inc. | Human Prescription Drug |
54436-022 | Otrexup | Methotrexate | Injection, Solution | Subcutaneous | Antares Pharma, Inc. | Human Prescription Drug |
54436-025 | Otrexup | Methotrexate | Injection, Solution | Subcutaneous | Antares Pharma, Inc. | Human Prescription Drug |